Every two years the political and media class tells us the midterms reshaped health policy. Most of the time they overstate it…by Reginald Hislop III
Historically, midterms don’t beget much new for federal health policy. This time, however, could be different as rising costs pushed to the consumer (the insured) in a period of overall inflation adds weight to the debate. This cycle, they may be understating it, not because the voters delivered a mandate on healthcare, but because the election changed the one thing that actually moves health policy in this country: who holds the gavel on the money.
The White House did not change hands, so the headline reads as continuity. That is the wrong way to read it. The midterm election health. policy story is not about a mandate. It is about the margins, the committees, and the political incentive to spend, and those three things determine more about what happens to Medicare, Medicaid, and the post-acute payment structure than any campaign platform does.
Similarly, and not to be ignored, changes in statehouses and legislatures can have an even more dramatic effect on things that people will feel more imminently. For example, adding back dollars for Medicaid incentives. As has occurred in Illinois and California, using dollars to insure undocumented aliens, even though under Medicaid, this is illegal. Adopting mandates for state-chartered insurance companies, adding additional layers of policy and bureaucracy are common state level policy issues that add systemic cost and frustrate providers.
The agenda is set by the chair, not the president
Health policy in Washington runs through a small number of committees, and the health policy committee changes this cycle redrew who sits at the top of them. The committees that write the Medicare and Medicaid authorizations, the appropriations that fund HHS, and the oversight that sets the enforcement tone all have new leadership, and new leadership means new priorities. Since this blog started sixteen plus years ago, I have followed and written extensively on the evolution of health policy at the federal level Policy and Politics – Federal – Reg’s Blog .
That matters more than the average provider prices in, because the chair decides what gets a hearing, what gets marked up, and what dies in committee without ever reaching a vote. The last two years of policy were shaped by the people who held those gavels. The next two will be shaped by whoever holds them now, and the outlook for health policy priorities in 2027 is the most direct way to read what is about to get funded and what is about to get squeezed.
There are two fights worth watching before the inaugural is even cold. The Medicare physician payment fix is one, because the costs of the fee-schedule reforms the providers are now agitating for flow back into the very payment models the post-acute side already lives inside 2027 Physician Fee Schedule Final Rule: What to Expect | DocWireNews . The second is the Medicare Advantage overpayment question, which comes back to the table every session and never gets settled. The midterms did not settle it either CBO Analysis Suggests $1 Trillion in Medicare Advantage Overpayments-2026-08-20 . They just changed who gets to frame the question next.
The money problem is the same before and after
Here is the part the political commentary misses and the providers understand instinctively. The election did not change the underlying fiscal math. Entitlement spending is still on a trajectory that outruns revenue, the Medicare Trust Fund still has a date on it, and the $76 billion the federal government pays Medicare Advantage plans above traditional Medicare is still sitting in the crosshairs regardless of who is in the room. Beyond Insolvency: The Bigger Picture of Medicare’s 2026 Financial Outlook | Medicare Policy Initiative
That is the constant. The variable is the political will to act on it, and the election moved that variable. A tighter margin and a more contested Congress make the incremental, technocratic fixes harder to pass and the large, blunt spending bills harder still. The result is rarely nothing. It is usually a version of the same squeeze we have been writing about — the Medicare payment changes after election already set in motion, the risk-model tightening, the audit expansion — delivered through the regulatory channel because the legislative channel is blocked.
The midterms did not create the V28 risk model or the RADV audits or the tighter Star methodology Decoding Medicare Advantage Coding Intensity | KFF . Those were set in motion across administrations and congresses, because the underlying problem — paying more than traditional Medicare while the trust fund runs down — persists no matter who wins. The election changed how fast and how publicly the next round of that tightening gets delivered.
What moves now, and what does not
The realistic read is that some priorities accelerate and others stall. Drug pricing and the Part D redesign already in motion will keep moving, because they are baked into the Inflation Reduction Act machinery and nobody is reopening that mid-implementation. The things that needed new legislation are the things now in question, and that list is longer than the commentariat wants to admit.
The workforce and staffing agenda is the clearest case, and it is the part of post-acute care policy that lands most directly on providers. The staffing mandate and the wage pressures on the post-acute workforce were always going to be litigated in the next Congress, and the election changed the venue and the advocates. Watch that one, because it lands directly on the skilled nursing and home health cost structure, and it is now more contested, not less Senate Democrats plot new course for nursing home staffing rule, spending oversight – McKnight’s Long-Term Care News. The same applies to any Medicaid policy changes 2027 brings, since the Medicaid side carries a growing share of the long-term care and dual-eligible cost that post-acute operators depend on.
The oversight machinery is the sleeper. A divided Washington does not legislate much, but it investigates constantly, and the committees that now hold the gavels on fraud, quality, and program integrity will set the tone for the next two years of False Claims Act, OIG, and survey activity. The providers who treat that as a background function are the ones who get surprised. The election did not change the statutes. It changed the appetite to enforce them.
The provider’s read, not the pundit’s
The pundit asks what the election means for the parties. The provider should ask what it means for the payment and the enforcement environment that shows up in the daily report, and the answer is more nuance than the panel shows. The margins are tighter, the committees are new, the spending is contested, and the regulatory channel is about to do more of the work that legislation used to do.
The agenda did not change in the ways that make banners. It changed in the ways that make margins: who writes the payment rules, who runs the oversight, and how much new money is actually available next year. The provider who wants to know what the midterms mean for their bottom line should stop watching the victory speeches and start watching the committee assignments. That is where health policy gets made, and that is where the election actually landed.
